GAMMA Investing LLC Sells 407 Shares of Xylem Inc. (NYSE:XYL)

GAMMA Investing LLC reduced its stake in Xylem Inc. (NYSE:XYLFree Report) by 11.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,285 shares of the industrial products company’s stock after selling 407 shares during the quarter. GAMMA Investing LLC’s holdings in Xylem were worth $381,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. State Street Corp increased its holdings in shares of Xylem by 1.9% during the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company’s stock valued at $1,394,792,000 after acquiring an additional 189,820 shares in the last quarter. Geode Capital Management LLC boosted its stake in Xylem by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company’s stock worth $762,804,000 after purchasing an additional 54,877 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Xylem by 1.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company’s stock valued at $465,760,000 after buying an additional 32,645 shares during the last quarter. Swedbank AB increased its position in shares of Xylem by 22.8% during the third quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock valued at $403,953,000 after acquiring an additional 554,609 shares in the last quarter. Finally, Impax Asset Management Group plc raised its holdings in Xylem by 1.0% in the 3rd quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock worth $226,555,000 after acquiring an additional 15,825 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

Shares of Xylem stock opened at $116.88 on Tuesday. The stock’s fifty day moving average is $122.45 and its 200 day moving average is $129.97. Xylem Inc. has a one year low of $109.39 and a one year high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. The stock has a market cap of $28.40 billion, a P/E ratio of 34.18, a P/E/G ratio of 2.22 and a beta of 1.06.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, hitting the consensus estimate of $1.11. The firm had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.17 billion. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The business’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter last year, the company earned $0.99 earnings per share. Sell-side analysts anticipate that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th were paid a $0.36 dividend. The ex-dividend date was Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.23%. Xylem’s dividend payout ratio (DPR) is presently 42.11%.

Analyst Upgrades and Downgrades

XYL has been the subject of a number of research analyst reports. TD Cowen reduced their target price on Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a report on Wednesday, November 6th. Wolfe Research reissued a “peer perform” rating on shares of Xylem in a research report on Thursday, December 12th. Citigroup raised shares of Xylem from a “neutral” rating to a “buy” rating and raised their price target for the company from $135.00 to $148.00 in a report on Monday, December 9th. Stifel Nicolaus lowered their price objective on shares of Xylem from $172.00 to $166.00 and set a “buy” rating on the stock in a research report on Wednesday, December 11th. Finally, Robert W. Baird cut their target price on shares of Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $152.20.

Check Out Our Latest Stock Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.